drugset / Trial / NCT01827124

Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption

NCT01827124

RandomizedFactorialTriple-blindPrevention

Summary

Intravenous Carbetocin is more efficient than intravenous infusion oxytocin in management of placental delivery in 2nd trimester interruption.

Timeline

Start
2013-04
Primary completion
2013-11
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 100 ug Intravenous
Subject Oxytocin Peptide 20 iu Intravenous

Indications

No indication recorded.